Halozyme Therapeutics (HALO) Q4 2014 Earnings

10NovConfirmed
Q1 2014
Q2 2014
Q3 2014
Q4 2014
-0.22
-0.19
-0.16
-0.13

Details

Expected EPS
-0.15
Actual EPS
-0.16
Surprise EPS
-0.01
Surprise Percent
+6.67%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.16 per share for Q4 2014.

0 Comments

Share your thoughts